Antenatal Betamethasone Does Not Impair Neurocognitive Function in Fetal Growth Restriction Antenatal Betamethasone Does Not Impair Neurocognitive Function in Fetal Growth Restriction

Repeated antenatal doses of betamethasone does not impair neurocognitive function in elementary-school-aged children born with fetal growth restriction, according to a secondary analysis from the ACTORDS clinical trial.Reuters Health Information
Source: Medscape Radiology Headlines - Category: Radiology Tags: Pediatrics News Source Type: news